Analyzing Arcadia Biosciences (NASDAQ:RKDA) and Oriental Rise Holdings Limited Ordinary Shares (NASDAQ:ORIS)

Oriental Rise Holdings Limited Ordinary Shares (NASDAQ:ORIS) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, earnings, risk and institutional ownership.

Valuation & Earnings

This table compares Oriental Rise Holdings Limited Ordinary Shares and Arcadia Biosciences”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oriental Rise Holdings Limited Ordinary Shares	$24.12 million	1.36	$11.50 million	N/A	N/A
Arcadia Biosciences	$5.48 million	1.52	-$13.98 million	($4.28)	-1.43

Oriental Rise Holdings Limited Ordinary Shares has higher revenue and earnings than Arcadia Biosciences.

Profitability

This table compares Oriental Rise Holdings Limited Ordinary Shares and Arcadia Biosciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Oriental Rise Holdings Limited Ordinary Shares	N/A	N/A	N/A
Arcadia Biosciences	-110.61%	-52.63%	-34.57%

Analyst Ratings

This is a summary of recent ratings for Oriental Rise Holdings Limited Ordinary Shares and Arcadia Biosciences, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oriental Rise Holdings Limited Ordinary Shares	0	0	0	0	0.00
Arcadia Biosciences	0	0	1	1	3.50

Arcadia Biosciences has a consensus price target of $6.00, suggesting a potential downside of 1.80%. Given Arcadia Biosciences’ stronger consensus rating and higher probable upside, analysts clearly believe Arcadia Biosciences is more favorable than Oriental Rise Holdings Limited Ordinary Shares.

Institutional and Insider Ownership

17.7% of Arcadia Biosciences shares are held by institutional investors. 1.8% of Arcadia Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Arcadia Biosciences beats Oriental Rise Holdings Limited Ordinary Shares on 7 of the 12 factors compared between the two stocks.

About Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Limited engages in planting, cultivating, processing, and selling processed tea in Mainland China. It offers processed white tea, black tea, and refined tea products to wholesale distributors and end-user retail customers. The company was incorporated in 2019 and is based in Ningde, China.

About Arcadia Biosciences

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.